The CXCR4–STAT3–IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The CXCR4–STAT3–IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-01-15
DOI
10.3389/fimmu.2017.01773
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation
- (2016) A. Sarvaria et al. BLOOD
- The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells
- (2015) D Saulep-Easton et al. LEUKEMIA
- How does lenalidomide target the chronic lymphocytic leukemia microenvironment?
- (2014) A. P. Kater et al. BLOOD
- TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells
- (2014) Bi-Sheng Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia
- (2014) S. Fiorcari et al. HAEMATOLOGICA
- Genetic and cytokine changes associated with symptomatic stages of CLL
- (2014) Amit Agarwal et al. LEUKEMIA RESEARCH
- Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer
- (2014) XIAOJIAN LIU et al. ONCOLOGY REPORTS
- Efficacy and safety of long-term treatment with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma
- (2014) M A Dimopoulos et al. Blood Cancer Journal
- Lenalidomide reduces survival of chronic lymphocytic leukemia cells in primary cocultures by altering the myeloid microenvironment
- (2013) A. Schulz et al. BLOOD
- Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemia
- (2013) P. Strati et al. BLOOD
- The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
- (2013) J. Hoellenriegel et al. BLOOD
- The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges
- (2013) A. P. Hutchins et al. Briefings in Functional Genomics
- Lenalidomide overcomes suppression of human natural killer cell anti-tumor functions by neuroblastoma microenvironment-associated IL-6 and TGFβ1
- (2013) Yibing Xu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adipose Natural Regulatory B Cells Negatively Control Adipose Tissue Inflammation
- (2013) Satoshi Nishimura et al. Cell Metabolism
- Tumor-induced host immunosuppression: Special focus on CLL
- (2013) Christine E. Cutucache INTERNATIONAL IMMUNOPHARMACOLOGY
- Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells
- (2013) Uri Rozovski et al. Molecular Cancer
- T Follicular Helper Cells Mediate Expansion of Regulatory B Cells via IL-21 in Lupus-Prone MRL/lpr Mice
- (2013) Xue Yang et al. PLoS One
- The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies
- (2013) Jan A. Burger et al. SEMINARS IN CANCER BIOLOGY
- CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer
- (2013) Hai-bo Shen et al. TUMOR BIOLOGY
- IL-10-producing regulatory B cells (B10 cells) in autoimmune disease
- (2013) Ioannis Kalampokis et al. ARTHRITIS RESEARCH & THERAPY
- Immune Regulatory Function of B Cells
- (2012) Claudia Mauri et al. Annual Review of Immunology
- Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
- (2012) A. G. Ramsay et al. BLOOD
- Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function
- (2012) D J DiLillo et al. LEUKEMIA
- INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
- (2012) AnnaMaria Nosari Mediterranean Journal of Hematology and Infectious Diseases
- Pharmacokinetics, metabolism and excretion of [14C]-lenalidomide following oral administration in healthy male subjects
- (2011) Nianhang Chen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
- (2011) E. Righi et al. CANCER RESEARCH
- Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells
- (2011) K. P. Piper et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- CD5 Promotes IL-10 Production in Chronic Lymphocytic Leukemia B Cells through STAT3 and NFAT2 Activation
- (2011) S. Garaud et al. JOURNAL OF IMMUNOLOGY
- Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia
- (2011) J. A. Burger Hematology-American Society of Hematology Education Program
- Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma
- (2010) G. Gorgun et al. BLOOD
- STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells
- (2010) I. Hazan-Halevy et al. BLOOD
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
- (2010) Paul A. Blair et al. IMMUNITY
- Inhibition of Constitutive Activation of STAT3 by Curcurbitacin-I (JSI-124) Sensitized Human B-Leukemia Cells to Apoptosis
- (2010) G. Ishdorj et al. MOLECULAR CANCER THERAPEUTICS
- Alternative implication of CXCR4 in JAK2/STAT3 activation in small cell lung cancer
- (2009) M Pfeiffer et al. BRITISH JOURNAL OF CANCER
- IL-10 interferes directly with TCR-induced IFN-γ but not IL-17 production in memory T cells
- (2009) Sandra Naundorf et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mechanism of action of lenalidomide in hematological malignancies
- (2009) Venumadhav Kotla et al. Journal of Hematology & Oncology
- Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
- (2008) A. Ferrajoli et al. BLOOD
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
- (2008) Koichi Yanaba et al. IMMUNITY
- Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug
- (2008) Alan G. Ramsay et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
- (2008) Takashi Matsushita et al. JOURNAL OF CLINICAL INVESTIGATION
- Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
- (2008) Apostolia-Maria Tsimberidou et al. JOURNAL OF CLINICAL ONCOLOGY
- CXCL12 (SDF-1α) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells
- (2008) Moran Meiron et al. JOURNAL OF EXPERIMENTAL MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now